Skip to main content
Clinical Trials/NCT06252038
NCT06252038
Recruiting
N/A

Rural Alliance for Diabetes Prevention

University of Kansas Medical Center1 site in 1 country160 target enrollmentSeptember 24, 2024
ConditionsPreDiabetes

Overview

Phase
N/A
Intervention
Not specified
Conditions
PreDiabetes
Sponsor
University of Kansas Medical Center
Enrollment
160
Locations
1
Primary Endpoint
Weight change across 12 months
Status
Recruiting
Last Updated
5 months ago

Overview

Brief Summary

The purpose of this randomized controlled trial is to compare the effectiveness of Cooperative Extension implementing two delivery methods (group video vs. self-directed) and participant recruitment strategies of the National Diabetes Prevention Program (NDPP) to adults in rural communities. Exploratory assessments of implementation facilitators and barriers will be completed to determine strategies that may impact intervention effectiveness and that may support or impede the implementation, dissemination, and effectiveness of Cooperative Extension to deliver the NDPP to prediabetic adults in rural areas.

Detailed Description

This 12 mo. Type II hybrid effectiveness-implementation trial will compare effectiveness (weight loss, physical activity, HbA1c) of Cooperative Extension delivering the Diabetes Prevention Program (DPP) by group video using Zoom® (GV) vs. a self-directed (SD) control. Active vs. passive participant recruitment strategies will be compared on recruitment outcomes including time to full enrollment, participant yield, and retention rates. Ten Cooperative Extension local units/districts serving rural Kansas counties will be allocated to either active or passive recruitment. Each of the sites will recruit adults with prediabetes living in the county served by Kansas State Research and Extension site and will be randomized to one of the 2 intervention arms. A centralized team of Cooperative Extension Agents who complete NDPP lifestyle coach training will serve as interventionists for both the GV and SD arms. Primary (weight) and secondary outcomes (HbA1c, the proportion of participants meeting weight loss (≥ 5%) and physical activity goals (≥150 min./wk.) will be assessed at baseline, 6 and 12 mos. Findings will inform best practices in the delivery of the DPP through Cooperative Extension in rural communities that could reach this high risk population.

Registry
clinicaltrials.gov
Start Date
September 24, 2024
End Date
May 31, 2028
Last Updated
5 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 18 years or older
  • BMI ≥25 kg/m2, ≥23 kg/m2 if Asian
  • Blood test results in the pre diabetic range within the last year (HbA1C = 5.7%-6.4% or fasting plasma glucose= 100-125 mg/dl or 2-hr. plasma glucose following a 75-gm glucose load = 140-199 mg/dL) or have previous diagnosis of gestational diabetes or a positive screening for pre diabetes based on CDC pre diabetes risk test
  • Willing to travel to KSRE site for orientation and outcome testing
  • Available to attend pre-specified meeting time of GV for their respective KSRE location
  • Medically stable as deemed by primary care provider consent
  • English speaking

Exclusion Criteria

  • Previous diagnosis of Type I or II diabetes
  • Taking FDA-approved weight loss medications
  • Primary care provider stating that patient should not participate
  • Self-report as currently pregnant or within 6 weeks of having given birth (or planning to become pregnant in the next 12 months)
  • Unable to engage in physical activity

Outcomes

Primary Outcomes

Weight change across 12 months

Time Frame: Baseline to 12 months

Weight (kg) will be assessed to the nearest 0.1 kg with a calibrated scale (Belfour Inc., Model #PS6600). All participants will be weighed between the hours of 6 and 10 am following an overnight fast of at least 8 hours in a standard hospital gown.

Secondary Outcomes

  • CDC-NDPP Weight Loss Goal(Baseline to 12 months)
  • CDC-NDPP Physical Activity Goal(Baseline to 12 months)
  • HbA1c change across 12 months(Baseline to 12 months)

Study Sites (1)

Loading locations...

Similar Trials